Business

Cardlytics Announces First Quarter 2025 Financial Results

ATLANTA--(BUSINESS WIRE)-- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the first quarter ended

articleCardlytics, Inc. Common StockMay 7, 20255/company/cardlytics-inc/news/cardlytics-announces-first-quarter-2025-financial-results-2025-05-07
Cardlytics Announces First Quarter 2025 Financial Results

About this update from Cardlytics, Inc. Common Stock

[{"type":"text","content":" ATLANTA--(BUSINESS WIRE)--\nCardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the first quarter ended March 31, 2025.\n\n\"We've made marked progress across our key business pillars, which continue to underpin our journey to 'platformize' Cardlytics and position ourselves as the leading commerce media platform,\" said Amit Gupta, CEO of Cardlytics. \"Our expanding ecosystem, depth and breadth of our data, and ongoing tech investments are strengthening our position and providing differentiated value to our partners and advertisers.\"\n\n\"We’ve built a resilient platform and are making strategic decisions as we look to future-proof our business,\" said Alexis DeSieno, CFO of Cardlytics. \"With recent actions to strengthen our balance sheet, we’re taking a targeted, disciplined approach to cost management while continuing to invest in key areas for growth.”\n\nFirst Quarter 2025 Financial Results\n\n\nRevenue was $61.9 million, a decrease of 8% year-over-year compared to $67.6 million in the first quarter of 2024.\n\n\nBillings, a non-GAAP metric, was $97.6 million, a decrease of 7% year-over-year compared to $105.2 million in the first quarter of 2024.\n\n\nAdjusted Contribution, a non-GAAP metric, was $32.4 million, a decrease of 12% year-over-year compared to $37.1 million in the first quarter of 2024.\n\n\nNet Loss was $(13.3) million, or $(0.26) per diluted share, based on 51.9 million fully diluted weighted-average common shares, compared to a Net Loss of $(24.3) million, or $(0.56) per diluted share, based on 43.2 million fully diluted weighted-average common shares in the first quarter of 2024.\n\n\nAdjusted EBITDA, a non-GAAP metric, was $(4.4) million compared to $0.2 million in the first quarter of 2024.\n\n\nAdjusted Net Loss was $(11.1) million, or $(0.21) per diluted share, based on 51.9 million fully diluted weighted-average common shares, compared to Adjusted Net Loss of $(4.1) million, or $(0.09) per diluted share, based on 43.2 million fully diluted weighted-average common shares in the first quarter of 2024.\n\n\nNet cash used in operating activities was $(6.7) million, compared to $(17.6) million in the first quarter of 2024.\n\n\nFree Cash Flow, a non-GAAP metric, was $(10.8) million, compared to $(22.4) million in the first quarter of 2024.\n\n\nKey Metric...

More updates from Cardlytics, Inc. Common Stock